Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients

被引：19

作者：

Kumarasamy, N ^{[1
]}

Vallabhaneni, S

Flanigan, TP

Balakrishnan, P

Cecelia, A

Carpenter, CCJ

Solomon, S

Mayer, KH

机构：

[1] VHS, YRG Ctr AIDS Res & Educ, Madras, Tamil Nadu, India

[2] Brown Univ, Miriam Hosp, Providence, RI 02912 USA

来源：

AIDS | 2005年 / 19卷 / 06期

关键词：

D O I：

10.1097/01.aids.0000163940.85940.03

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We prospectively studied the initial results of 6 months of generic efavirenz-based therapy on the plasma viral load in 40 patients at YRG Centre for AIDS Research and Education, a tertiary HIV referral centre in southern India. The median baseline plasma viral load was 259 000 copies/ml and at 6 months 95% of patients had plasma viral loads less than 400 copies/ml. The data support the use of generic non-nucleoside reverse transcriptase inhibitor-based regimens in resource-limited settings.

引用

页码：625 / 627

页数：3

共 10 条

[1] Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors [J].

Behrens, G ;

Dejam, A ;

Schmidt, H ;

Balks, HJ ;

Brabant, G ;

Körner, T ;

Stoll, M ;

Schmidt, RE .

AIDS, 1999, 13 (10) :F63-F70

[2] Comparison of generic zidovudine plus lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets [J].

Henry, K ;

Brundage, R ;

Weller, D ;

Akinsete, O ;

Shet, A .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (05) :537-537

[3]

HOSSEINPOUR M, 2003, 10 C RETR OPP INF BO

[4] The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India [J].

Kumarasamy, N ;

Solomon, S ;

Chaguturu, SK ;

Mahajan, AP ;

Flanigan, TP ;

Balakrishnan, P ;

Mayer, KH .

AIDS, 2003, 17 (15) :2267-2269

[5] Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon:: open-label multicentre trial [J].

Laurent, C ;

Kouanfack, C ;

Koulla-Shiro, S ;

Nkoué, N ;

Bourgeois, A ;

Calmy, A ;

Lactuock, B ;

Nzeusseu, V ;

Mougnutou, R ;

Peytavin, G ;

Liégeois, F ;

Nerrienet, E ;

Tardy, M ;

Peeters, M ;

Andrieux-Meyer, I ;

Zekeng, L ;

Kazatchkine, M ;

Mpoudi-Ngolé, E ;

Delaporte, E .

LANCET, 2004, 364 (9428) :29-34

[6] Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection [J].

Robbins, GK ;

De Gruttola, V ;

Shafer, RW ;

Smeaton, LM ;

Snyder, SW ;

Pettinelli, C ;

Dube, MP ;

Fischl, MA ;

Pollard, RB ;

Delapenha, R ;

Gedeon, L ;

van der Horst, C ;

Murphy, RL ;

Becker, MI ;

D'Aquila, RT ;

Vella, S ;

Merigan, TC ;

Hirsch, MS ;

Nokta, M ;

Johnson, V ;

Morse, G ;

Putnam, B ;

Klebert, M ;

Martinez, A ;

Chiesi, A ;

Tomino, C ;

Deeks, S ;

Testa, M ;

Nevin, T ;

Levin, J ;

French, V ;

Fennell, O ;

Stevens, M ;

Grosso, R ;

Dusak, B ;

Hodder, S ;

Squibb, M ;

Brothers, C ;

Tolson, J ;

Leavitt, R ;

Manion, D ;

Ruiz, N ;

Morrisey, K ;

Quart, B ;

Jennings, C ;

Dascomb, S ;

Cooper, M ;

Murphy, M ;

Blakelock, K ;

Doolan, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24) :2293-2303

[7] Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults [J].

Staszewski, S ;

Morales-Ramirez, J ;

Tashima, KT ;

Rachlis, A ;

Skiest, D ;

Stanford, J ;

Stryker, R ;

Johnson, P ;

Labriola, DF ;

Farina, D ;

Manion, DJ ;

Ruiz, NM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1865-1873

[8]

THOMPSON M, 1999, 6 C RETR OPP INF 31

[9] Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study [J].

van Leth, F ;

Phanuphak, P ;

Ruxrungtham, K ;

Baraldi, E ;

Miller, S ;

Gazzard, B ;

Cahn, P ;

Lalloo, UG ;

van der Westhuizen, IP ;

Malan, DR ;

Johnson, MA ;

Santos, BR ;

Mulcahy, F ;

Wood, R ;

Levi, GC ;

Reboredo, G ;

Squires, K ;

Cassetti, I ;

Petit, D ;

Raffi, F ;

Katlama, C ;

Murphy, RL ;

Horban, A ;

Dam, JP ;

Hassink, E ;

van Leeuwen, R ;

Robinson, P ;

Wit, FW ;

Lange, JMA .

LANCET, 2004, 363 (9417) :1253-1263

[10]

WHO, 2003, SCAL ANT THER RES LT

← 1 →